Tierney Saccavino | EVP, Corporate Communications |
Ron Cohen | Founder, CEO, President & Director |
Michael Gesser | CFO |
Welcome to Acorda Therapeutics Second Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.
I will now introduce your host for today's call, Tierney Saccavino with Acorda.